NEWS
Alborizina et al 2023
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/07/Alborizina-et-al23.png
681
633
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-07-12 17:59:392023-09-21 10:54:09EMBO Mol Med.: LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma
Helmholtz Munich | ©Claudia Dalke
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/09/DSC_0999-mod-v16062023-for-Nakamura-et-al-Nature-2023.jpg
816
1280
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-07-12 09:10:212024-01-22 13:11:41Nature: Phase separation of FSP1 promotes ferroptosis.
Alborzinia et al., 2022
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/07/Alborizina-et-al22.png
628
683
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-04-28 17:58:502023-09-21 11:28:32Nat cancer: MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis

